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Abstract 
Alcohol dehydrogenases (ADHs) are applied in industrial synthetic chemistry for the 
production of optically active secondary alcohols.  However, the substrate spectrum of many 
ADHs is narrow, and few, for example, are suitable for the reduction of prochiral ketones in 
which the carbonyl group is bounded by two bulky and/or hydrophobic groups; so-called 
‘bulky-bulky’ ketones. Recently two ADHs, RasADH from Ralstonia sp. DSM 6428, and 
SyADH from Sphingobium yanoikuyae DSM 6900, have been described, which are 
distinguished by their ability to accept bulky-bulky ketones as substrates.  In order to 
examine the molecular basis of the recognition of these substrates the structures of the native 
and NADPH complex of RasADH, and the NADPH complex of SyADH have been 
determined and refined to resolutions of 1.5, 2.9 and 2.5 Å respectively.  The structures 
reveal hydrophobic active site tunnels near the surface of the enzymes that are well-suited to 
the recognition of large hydrophobic substrates, as determined by modelling of the bulky-
bulky substrate n-pentyl phenyl ketone.  The structures also reveal the bases for NADPH 
specificity and (S)-stereoselectivity in each of the biocatalysts for n-pentyl phenyl ketone and 
related substrates. 
 
 
 
 
 
 
 
 
 
Introduction 
Alcohol dehydrogenases (ADHs) have been employed for many years in both academic and 
industrial groups for the asymmetric reduction of prochiral carbonyl groups to optically 
active secondary alcohols [1,2]. The natural diversity of ADHs has ensured that enzymes 
encompassing a broad range of catalytic characteristics have been made available for 
applications.  Hence there are ADHs that offer (R)- [3] or (S)-[4] selectivity, thermostability 
[5,6] and an impressive tolerance to organic solvents that allows the enzymes to be used in 
the presence of high substrate concentration [4] or even neat substrate itself [7]. One such 
niche application of ADHs is served by a subgroup of these enzymes that transforms 
prochiral ketones that feature large hydrophobic groups on either side of the carbonyl group; 
‘bulky-bulky’ ketones.   
As part of a culture collection screening programme, Kroutil and co-workers described the 
cloning, expression and application of an ADH from Ralstonia sp. DSM 6428, which was 
able to accept these bulky-bulky ketones as substrates [8]. The Ralstonia ADH (RasADH 
from hereon) enzyme was applied to the reduction of n-butyl phenyl ketone and n-pentyl 
phenyl ketone 1 with (S)-enantioselectivity and with enantiomeric excesses (e.e.s) of up to 
>99% (Figure 1) [8]. The excellent enantioselectivity was also extended to bulky-small 
ketones such as acetophenone.  RasADH has subsequently been characterised in some detail 
by one of our groups [9]. The enzyme was reported to be of the short chain dehydrogenase 
(SDR) family, with a subunit molecular weight of 26.7 kDa (249 amino acids) and it was 
suggested that three subunits of the enzyme associated to form a trimer in solution. RasADH 
exhibited a broad pH optimum for the reductive transformation of benzaldehyde and had a 
half-life of 80 h at 25°C.  The stability of the enzyme could be augmented by the addition of 
calcium ions.  RasADH was subsequently also applied to the reduction of -hydroxy ketones 
[10] and in the dynamic kinetic resolution (DKR) of -alkyl--keto esters such as 3 (Figure 
1) to give (2S, 3S)- products of type 4 [11].
 
Further screening of microbial culture collections for the reduction of bulky-bulky ketones 
revealed a strain of Sphingobium yanoikuyae DSM 6900 that was also able to reduce n-pentyl 
phenyl ketone 1 to the (S)-alcohol 2 in up to 97% e.e. [12].  This short chain dehydrogenase, 
named SyADH, was isolated and the relevant gene cloned and expressed, and subsequently 
used for the non-selective oxidation of some small prochiral alcohols [13]. Like RasADH, 
SyADH has also recently been employed in the DKR of -alkyl--keto esters such as 5 [11], 
in this case to give (2R, 3S)- diol products 6 with excellent d.e.s and e.e.s 
RasADH and SyADH therefore present distinctly useful biocatalysts as they catalyse the 
transformation of sterically challenging substrates and with, in some cases, complementary 
stereo- and diastereo-selectivities to established ADHs.  In the case of each of these enzymes, 
knowledge of their three-dimensional structure would not only provide information for the 
first time on the determinants of bulk-bulky ketone recognition in such ADHs, but also serve 
to inform the engineering of other ADHs for transformation of those substrates, or for the 
expanded substrate specificity of RasADH and SyADH themselves.  In this report, we 
present the X-ray crystal structures of the apo- and NADPH-complex of RasADH at 1.5 Å 
and 2.9 Å resolution respectively, and also the structure of the NADPH complex of SyADH 
at 2.5 Å resolution.  These structures reveal the hydrophobic characteristics of the active 
site(s) that allow accommodation of large hydrophobic substrates, and also shed light on the 
determinants of cofactor specificity in these ‘bulky-bulky’ ADH enzymes. 
 
Results and Discussion 
Structure of RasADH 
RasADH was expressed from a strain of E. coli BL21 (DE3) that had been transformed with 
the gene encoding RasADH ligated into the pET-YSBLIC-3C vector [14]. After purification 
using nickel affinity and gel filtration chromatography, the pure protein was initially 
concentrated to 8 mg mL
-1
.  During this process problems with precipitation were 
encountered, but these were successfully addressed through the inclusion of Ca
2+
 ions, 500 
mM sodium chloride and glycerol in the cell resuspension and protein purification buffers 
(see Experimental Section). Gel filtration studies on the protein derived in this way were 
suggestive of a tetramer of RasADH monomers in solution, rather than the trimer suggested 
by earlier studies [9]. 
Crystals of RasADH were obtained in two forms, each of which was soaked with 10 mM 
NADPH before testing diffraction quality.  It was found that the first form diffracted to a 
resolution of 1.5 Å with a C21 space group.  Data collection and refinement statistics can be 
found in Table 1.  The structure of RasADH was solved by molecular replacement using a 
monomer of a ‘probable dehydrogenase protein’ from Rhizobium etli CFN42 (55% sequence 
identity with RasADH; PDB code 4FGS) as a model.  In the structure solution there were 
four monomers A-D in the asymmetric unit, which made up a tetramer (Figure 2a), a 
quaternary association common to some other short-chain ADHs such as the carbonyl 
reductase from Candida parapsilosis (PDB code 3CTM, [15]) and levodione reductase from 
Corynebacterium aquaticum (1IY8, [16]). 
Each monomer of RasADH (Figure 2b) was made up of a classical Rossman fold with a 
central -sheet composed of seven-strands:  1 (residues 8-13); 2 (33-37); 3 (54-58); 4 
(83-87); 5 (131-135); 6 (174-180) and 7 (239-242).  The -sheet was surrounded by six 
alpha helices: 1 (residues 17-30); 2 (40-50); 3 (64-77);  4 (101-126); 5 (148-168) and 
7 (217-228).  A further helix, the sixth in sequence order 6 (195-208, as revealed by the 
NADPH complex structure – vide infra), was largely missing from the density in the apo 
structure of RasADH.  This helix was part of a sequence of residues in the region of Thr185 
to Phe205 that in each subunit could not be modelled (although residues Glu200 to Lys204 
were present in subunit ‘C’).  A possible role for this helix is discussed below.  
Notwithstanding helix 6, the overall fold of the RasADH monomer (Figure 2b) is well-
conserved amongst SDR structures; a superimposition of the ‘A’-chain of RasADH with that 
of a monomer of 4FGS gave an r.m.sd. of 0.71 Å over 240 Catoms.  The RasADH 
monomer is most similar to 4FGS and a putative oxidoreductase protein from Sinorhizobium 
meliloti 1021, (PDB code 4ESO; with 41% sequence identity to RasADH), as determined by 
analysis using the DALI server
 
[17], with r.m.s.d values for the latter structure 1.4 Å. over 
250 residues.  In this first, higher resolution, structure of RasADH no residual density in the 
omit map corresponding to the NADP(H) cofactor could be observed in the putative active 
site of the enzyme.  
 
A monomer of RasADH (for example, subunit ‘A’) closely associates with its neighbours ‘C’ 
and ‘B’, and to a lesser extent, ‘D’, to form the tetramer.  Subunit ‘A’ makes a contact surface 
area of 1540 Å
2
 with subunit ‘C’, as calculated using PISA [18], with interactions dominated 
by the reciprocal association of helices 7, including stacking interactions between Phe226 
residues of each subunit, and strands 7, which are largely governed by hydrophobic side-
chain interactions.  ‘A’ also closely interacts with subunit ‘B’, with a calculated shared 
interface of 1670 Å
2
. This pair of monomers interacts most closely through reciprocal 
interactions between helices 4 and 5, including the indole nitrogen of Trp164 of ‘A’ with 
the carboxylate side chain of ‘B’ Asp148 and a salt bridge between the side-chains of ‘A’ 
Asp105 and ‘B’ Arg 113.  
The other crystal form of RasADH diffracted more poorly, to a resolution of 2.9 Å, and in the 
same C21 space group as the apo-enzyme.  Using the monomer of the apo-structure as a 
model, the structure solution in this instance yielded six monomers in the asymmetric unit, 
representing one full tetramer and one half-tetramer.  In this case, each monomer featured 
extensive density in the omit map in the active site that was representative of the cofactor 
NADPH at full occupancy.  In addition, density for the helix  in the region of Thr185 to 
Phe205 was now largely complete, and could be modelled, save for one or two residues in the 
region of Val191.  Chain ‘F’ was complete, however.  The loop density in the NADPH 
complex confirmed that the loop appears to act as lid for the active site, closing over the 
cofactor in the holo-form of the enzyme (Figure 2b). 
 
Structure of SyADH 
SyADH was also subcloned into the pET-YSBLIC-3C vector, and was again expressed well 
in the soluble fraction of the BL21 (DE3) strain of E. coli.  In this case however, gel filtration 
analysis suggested that SyADH was predominantly a dimer in solution.  Crystallisation of 
SyADH followed cleavage of the hexahistidine tag as described in the Experimental Section.  
Crystals were of the P21 space group.  The structure was solved using the programme 
BALBES [19], which selected a monomer of the NADPH-dependent blue fluorescent protein 
from Vibrio vulificus (3P19; 25% sequence identity with SyADH) as a model.  The solution 
featured five dimer pairs in the asymmetric unit (Figure 3a).   
The monomer of SyADH (Subunit ‘A’ will serve as the model for the description below), 
again features the characteristic Rossman-type fold, again featuring a central -sheet of seven 
strands: 1 (residues 6-11);  2 (31-34);  3 (56-58);  4 (82-88);  5 (134-138);  6 (177-
181) and  7 (224-225). In SyADH, the sheet is surrounded by seven -helices:  1 (residues 
15-27); 2 (38-52) 3 (66-78); 4 (102-130); 5 (151-171) 6 (190-194) and 7 (207-220).  
A last helix, 8, stretching from residues 234-238, is at the C-terminus of the protein and 
participates in pronounced monomer-monomer (‘A’/’B’) interactions, helping to form the 
dimer (Figure 3b). Electron density allowed the modelling of residues Thr3 or Leu 4 through 
Tyr258 in all subunits, with only residue Asn199 not modeled in subunits ‘I’ and ‘J’, owing 
to poor electron density.  The monomer of SyADH was most similar to monomers of 
clavulanic acid dehydrogenase from Streptomyces clavuligerus (PDB code 2JAH; 26% 
sequence identity with SyADH; r.m.s.d 2.2 Å over 245 Catoms) [20] and sepiapterin 
reductase from Chlorobium tepidum (PDB code 2BD0; 25% sequence identity with SyADH; 
r.m.s.d 2.4 Å over 240 Catoms) [21]  The overall structural fold of the monomer of SyADH 
was very similar to that of 2JAH, save for a loop region Phe218-Leu223 between 7 and 7 
in SyADH which was longer in 2JAH (Ala227 –Val236).  Monomer ‘A’ was calculated to 
form an interface of 3700 Å
2
 with its dimer partner, subunit ‘B’, as calculated using PISA 
[18].  The dimer is stabilised by reciprocal interactions between residues in helices 8, 
including a salt bridge between the side-chain of residues Asp248 and Arg234 in each 
subunit, but also reciprocal interactions between 4 and 5, which are structurally 
homologous with helices 4 and  in RasADH, described above. 
 
The substrate binding sites 
The active site of RasADH is a hydrophobic tunnel that is formed at the top of the central -
sheet of the Rossman fold as seen in Figure 2b and Figure 4, and is partially covered by 
helix 6 in the NADPH-complex structure.  The nicotinamide ring of NADPH sits at the base 
of this tunnel, lined by residues Tyr150 (the likely proton donor to a nascent alcohol in the 
reductive ADH-catalysed reaction [22]), Ser137, Phe205, Leu144, Leu142, Leu201, Val138, 
Ile91, His147 and Gln191. The strict specificity for the phosphorylated cofactor NADPH is 
governed by interactions of adjacent arginine residues Arg38 and Arg39 and Asn15, with 
Arg38 also participating in -stacking interactions with the adenine ring.  The interactions 
with the phosphate explain the preference of RasADH for NADPH over the non-
phosphorylated cofactor NADH. 
The active site tunnel in SyADH is situated between two loops formed by Gly195-Val204 
and Phe144-Met150, the former in place of helix 6 in RasADH. The nicotinamide ring 
again occupies the base of the tunnel, the lining of which shares significant homology with 
RasADH, with probable proton donor Tyr153 (Ras-ADH-Tyr150), Ser140 (Ser137), Met150 
(His147),and Val141 (Val138), conserved in respect of steric bulk, but with three larger 
hydrophobic residues from RasADH replaced by alanine: Ala92 (equivalent to RasADH 
Ile91) and Ala145 (Leu142) and Ala194 (Gln191), suggestive, at least superficially, of a 
greater active site volume in SyADH overall. Additional steric bulk is provided in the active 
site by Trp191 (Ile188) and Phe148 (Leu144).  The 2’-ribose phosphate group of NADPH is 
less constrained in SyADH than in RasADH; Arg36 mirrors the location and function of 
RasADH-Arg38, but RasADH-Arg39 is not present and is replaced by an aspartate (Asp37) 
that points away from the phosphate binding site.  Ser13 replaces RasADH Gln15 in the other 
direct interaction with phosphate.  The side-chain of an additional arginine, Arg40, which is 
not present in RasADH is close to the phosphate in SyADH, but, with both terminal N-atoms 
of the side chain at 3.6 Å and 3.8 Å from the phosphate oxygen, too far away to suggest a 
major role in phosphate binding. 
 
The nicotinamide rings of the NADPH cofactors in each case are presented to the active site 
cavity. The C4 atom of the nicotinamide ring, from which hydride will be delivered to the 
substrate carbonyl, is in each case 4.2 Å (RasADH) or 4.3 Å (SyADH) from the phenolic 
hydroxyl of the tyrosine proton donor.  In SyADH, the region extending from the space 
between the nicotinamide C4 and the phenolic hydroxyl of Tyr153, and out into the 
hydrophobic cavity, contained electron density although no obvious ligands that featured in 
the crystallization conditions could be modelled.   
 
Modelling bulky-bulky ketones in the active sites 
RasADH and SyADH are distinctive in their ability to reduce  ketones in which the prochiral 
carbonyl group is bounded on either side by hydrophobic groups, such as  n-pentyl phenyl 
ketone 1, which is transformed by each enzyme into the (S)-alcohol with excellent 
enantiomeric excess, thus exhibiting a Prelog selectivity [23].  With the structures of the 
enzymes in hand, it was now possible to model the structure of 1 into their active sites, in the 
knowledge that, given the known (S)-stereospecificity of the enzymes with this substrate, 
only the re-face of the prochiral ketone would be presented to the C4-nicotinamide atom that 
delivers hydride, and also that the carbonyl group must be situated within H-bonding distance 
of the relevant conserved serines (Ser137 in RasADH and S140 in SyADH) and tyrosine 
proton donors (Tyr150 in RasADH and Tyr153 in SyADH) that are involved in catalysis 
[22]. 1 was modelled into the active sites of RasADH and SyADH using the programme 
AUTODOCK-VINA [24] applying a procedure described in the Experimental Section.  A 
comparison of these models is shown in Figure 5.  
 
In the model of SyADH with substrate 1, the hydrophobic tunnel can be described in terms of 
a proximal region nearer the surface of the enzyme, in which the phenyl ring is bound, and a 
distal region towards the enzyme interior, which binds the alkyl chain.  The re-face of the 
carbonyl in 1 is situated against the nicotinamide ring of NADPH, with the C=O oxygen 
positioned between the side chains of putative proton donor Tyr153 and Ser140.  As a 
consequence, the phenyl ring is accommodated in the proximal region of the tunnel, bounded 
by hydrophobic residues Val141, Ala184, Leu201 and Phe148.   The pendant n-pentyl group 
penetrates the distal region of the tunnel and is bounded by further hydrophobic residues 
Trp191, Ile190, Ala92 and Met150. In RasADH, the requisite interactions of the carbonyl 
group with the C4 of NADPH and the side chains of Tyr150 and Ser137 are still observed, 
but the phenyl ring of the substrate is pressed further into the active site in relation to the 
SyADH model complex, as a result of steric repulsion by residue Phe205, which is part of the 
‘lid’ helix 6.  In the distal region of the hydrophobic tunnel, penetration of the n-pentyl 
chain is prevented by Gln191 and is displaced into the region of the active site occupied by 
Ile188, which would not be permitted in SyADH because of the presence of bulky Trp191 
(seen behind the substrate in Figure 5a). The alkyl chain now makes favourable hydrophobic 
interactions in this position with Phe205 and Ile188 (seen behind the substrate in Figure 4b).  
The models suggest that although each accepts 1, SyADH is better suited to accommodate the 
substrate.  The models are useful in revealing the hydrophobic characteristics of the active 
sites that permit binding of hydrophobic substrates but also the distinctive substrate ranges of 
SyADH and RasADH.  The model suggest that while the flexible alkyl chain of 1 can be 
accommodated in the distal region of hydrophobic tunnel through contortion in RasADH, less 
flexible substituents, such as aromatics, would not be accommodated.  This is supported by 
substrate specificity studies [9], which show that compounds such as benzoin are poor 
substrates for RasADH. For SyADH, however, the larger distal portion of the hydrophobic 
tunnel may allow for the accommodation of such bulky groups.  The large capacity of the 
hydrophobic tunnel of SyADH also suggests a basis for its non-selectivity towards smaller 
prochiral ketones such as acetophenone [13] with space available for these substrates to be 
accommodated in such a way that presents the si- or the re- face of the carbonyl group to the 
NADPH hydride at C4 of the cofactor nicotinamide ring. 
 
Interestingly, from Figure 5 the models suggest that, in both cases, NADPH provides its pro-
S hydride to attack the re-face of the carbonyl moiety of n-pentyl phenyl ketone, suggesting 
that the reaction proceeds by the ‘E4 pathway’ [25]. Whilst the confirmation of pro-S hydride 
transfer in RasADH and SyADH awaits analysis using experiments with C4-deuterated 
cofactors, the structural observation is in agreement with the observed  stereospecificity of 
hydride delivery by other short chain ADHs with Prelog selectivity [26, 27].  Other ADHs or 
Prelog selectivity such as yeast [YADH, 28], horse liver [HLADH, 29], Rhodococcus 
erythropolis [30], or Thermoanaerobacter ethanolicus [31] ADHs, supply the NADPH pro-R 
hydride, thus following the E3 pathway [25], but in these cases the enzymes are of the zinc-
dependent Medium Chain Reductase (MDR) family, in which the opposite face of the 
nicotinamide ring (of NADH in these cases) is presented to the active site, through rotation 
around the bond between the nicotinamide ring and the ribose, relative to the conformation 
observed in the SDR, and as seen in PDB structures 2HCY (YADH, [32]) and 1LDE 
(HLADH). 
Conclusion 
The structures of RasADH and SyADH have revealed the structural basis for the recognition 
of bulky-bulky ketones in a hydrophobic tunnel near the surface of the enzymes.  The 
structures of enzymes with potential use in biocatalytic applications can be valuable in 
identifying active site determinants of substrate specificity and enantioselectivity that may 
inform rational engineering, or randomised mutagenesis at targeted residues, for improved or 
altered specificity.   
 
Experimental Section 
Gene cloning, expression and protein purification 
The genes encoding RasADH and SyADH were obtained from the laboratory of Professor 
Wolfgang Kroutil, University of Graz, Austria.  Each gene was sub-cloned into the pET-
YSBLIC-3C vector in York.  RasADH was amplified by PCR from the template plasmid 
using the following primers: 5’- 
CCAGGGACCAGCAATGTATCGTCTGCTGAATAAAACCGCAGTTATTACCG -3’ 
(Forward) and 5’- 
GAGGAGAAGGCGCGTTATTAAACCTGGGTCAGACCACCATCAACAAACAG -3’ 
(Reverse). SyADH was amplified using primers 5’- 
CCAGGGACCAGCAATGACCACCCTGCCGACCGTTCTG -3’ (Forward) and 5’- 
GAGGAGAAGGCGCGTTATTATTATTTTTCAAACTGCGGATGTGACCATGC -3’ 
(Reverse).  Following agarose gel analysis of the PCR products, the relevant bands were 
eluted from the gels using a PCR Cleanup kit® (Qiagen).  The genes were then sub-cloned 
into the pET-YSBL-LIC-3C vector using previously published techniques [14].  The resultant 
plasmids were then used to transform E. coli XL1-Blue cells (Novagen), yielding colonies 
which in turn gave plasmids using standard miniprep procedures that were sequenced to 
confirm the identity and sequence of the genes.  
 
The recombinant vector(s) containing the RasADH and SyADH genes were used to transform 
E. coli BL21 (DE3) cells using 30 g mL-1 kanamycin as antibiotic marker on Luria Bertani 
(LB) agar.  Single colonies from agar plate grown overnight were used to inoculate 5 mL  
cultures of LB broth, which were then grown overnight at 37°C with shaking at 180 r.p.m. 
The starter cultures served as inocula for a 1 L cultures of LB broth in which cells were 
grown until the optical density (OD600) had reached a value of 0.8.  Expression of either 
RasADH or SyADH were then induced by the addition of 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG).  The cultures were then incubated at 18°C in an orbital shaker 
at 180 r.p.m. for approximately 18 h.  The cells were harvested by centrifugation for 15 min 
at 4225 g in a Sorvall GS3 rotor in a Sorvall RC5B Plus centrifuge.  At this point, 
considerations specific to each protein applied and purification strategies diverged. 
 
For RasADH, cell pellets were resuspended in 20 mL of 50 mM Tris-HCl buffer pH 7.5 
containing 500 mM NaCl, 20 mM imidazole, 1 mM CaCl2 and 10% glycerol (v/v) (buffer 
‘A‘) per 1 L of cell culture. The cell suspensions were then sonicated for 10 x 45s bursts at 
4°C with 30 s  intervals.  The soluble and insoluble fractions were separated by centrifugation 
for 30 min at 26,892 g in a Sorvall SS34 rotor. The crude cell lysate from  1L cell culture was 
loaded onto a 5 mL HisTrap FF crude column (GE Healthcare), which was then washed with 
buffer ‘A‘) and then the protein eluted with a linear gradient of 20-300 mM imidazole over 
20 column volumes at a flow rate of 2.5 mL min
-1
.  Fractions containing RasADH  were 
combined and concentrated using a 10 kDa cut-off Centricon® filter membrane. The 
concentrated RasADH was then loaded onto a pre-equilibrated S75 Superdex™ 16/60 gel 
filtration column, which was then eluted with 120 mL of buffer ‘A‘ without imidazole, using 
a flow rate of 1 ml min
-1
. Fractions containing pure RasADH, as determined by SDS-PAGE 
analysis were combined and stored at 4°C. For SyADH, an equivalent procedure was 
employed using, in place of buffer ‘A‘, a 50 mM Tris-HCl buffer containing 300 mM NaCl 
and 20 mM imidazole only (buffer ‘B‘). All subsequent procedures were equivalent to the 
strategy employed for RasADH, with purification performed using Ni-NTA chromatography 
followed by gel filtration.  In the case of SyADH, prior to crystallisation, the histidine tag 
was cleaved using C3 protease using a procedure described previously [14].
 
 
Protein Crystallisation 
Crystallization conditions for both enzymes were determined using commercially available 
screens in the sitting-drop format in 96-well plates using 300 nL drops (150 nL protein plus 
150 nL precipitant solution). Positive hits were scaled up in 24 well Linbro dishes using the 
hanging-drop method of crystallisation, with crystallisation drops containing 1 L of protein 
solution and 1 L of precipitant reservoir.  For the apo-RasADH, the best crystals were 
obtained in 0.1M Bis-tris propane pH 7.0 containing 20% (w/v) PEG 3350 and 0.02 M 
sodium-potassium phosphate.  The protein concentration was 24 mg mL
-1
.  For the Ras-ADH 
NADPH complex, the best crystals were obtained in 0.1M Bis-tris propane pH 8.0, 
containing 16% (w/v) PEG 3350, 0.2M potassium isothiocyanate and 5% (w/v) ethylene 
glycol. The protein concentration in each case was 24 mg mL
-1
.  In each case, the crystals 
were picked and transferred to a solution of the mother liquor containing 20% (v/v) ethylene 
glycol as cryoprotectant and 10 mM NADPH, and left for 5 min.  The crystals were then 
flash cooled in liquid nitrogen prior to diffraction analysis. 
For the SyADH-NADPH complex, the best initial crystals were obtained in conditions 
containing 0.1M MES buffer pH 5.5 with 0.3 M sodium acetate and  15% (w/v) PEG 4K, 
with a protein concentration of 20 mg mL
-1
.  As with RasADH, crystals were picked and 
transferred to a solution of the mother liquor containing 20% (v/v) ethylene glycol as 
cryoprotectant and 10 mM NADPH, and left for 5 min.  The crystals were then flash-cooled 
in liquid nitrogen prior to diffraction analysis.  
Crystals were tested for diffraction using a Rigaku Micromax-007HF fitted with Osmic 
multilayer optics and a Marresearch MAR345 imaging plate detector. Those crystals that 
diffracted to greater than 3 Å resolution were retained for full dataset collection at the 
synchrotron. 
 
Data Collection, Structure Solution, Model Building and Refinement of Q1EQE0 
Complete datasets for the apo-RasADH and its NADH complex, and the SyADH complex 
with NADPH were collected on beamlines I04, I02 and I04 respectively, at the Diamond 
Light Source, Didcot, Oxfordshire, U.K.  Data were processed and integrated using XDS [33] 
and scaled using SCALA [34] as part of the Xia2 processing system [35]. Data collection 
statistics are given in Table 1.   The structure of the apo-RasADH was solved using 
MOLREP [36], using a monomer of structure PDB code 4FGS as a search model.  The 
solution contained four molecules in the asymmetric unit, representing one tetramer. The 
structure of the RasADH NADPH complex was then solved using the monomer of the apo-
RasADH.  The structure of SyADH was solved using the programme BALBES [19], which 
selected a monomer of the PDB code structure 3P19 as a model.   The solution contained five 
dimers in the asymmetric unit. All structures were built and refined using iterative cycles of 
Coot [37] and REFMAC [38] employing local NCS restraints.  For NADPH complexes of 
both RasADH and SyADH, the omit maps, after building and refinement of the proteins, 
revealed  residual density at the active sites, which could in each case be successfuly 
modelled and refined as NADPH. The final structures of apo-RasADH, Ras-ADH (NADPH) 
and SyADH (NADPH) exhibited Rcryst and Rfree values of 15.8/18.8%, 26.8/29.3% and 
23.4/25.1 respectively.  The structures were validated using PROCHECK [39].  Refinement 
statistics are presented in Table 1.  The Ramachandran plot for apo-RasADH showed 97.8% 
of residues to be situated in the most favoured regions, 1.6% in additional allowed and 0.5% 
outlier residues.  For the Ras-ADH-NADPH complex, the corresponding values were 95.3%, 
4.6% and 0.1% respectively.  For the SyADH-NADPH complex, the corresponding values 
were 99.0% and 1% with no residues in outlier regions. Coordinates and structure factors for 
apo-RasADH Ras-NADPH and SyADH-NADPH have been deposited in the Protein Data 
Bank with the accession codes 4bmn, 4bms and 4bmv respectively. 
 
Docking 
Automated docking was performed using AUTODOCK VINA 1.1.2 [25]. Structures for 
RasADH, SyADH were prepared using AUTODOCK utility scripts. Coordinates for 
substrate 1 were prepared using PRODRG [40].  A monomer model was used for RasADH 
and a dimer model was used for SyADH with the appropriate pdbqt files prepared in 
AUTODOCK Tools. The active site of RasADH and SyADH was contained in a grid of 20 x 
30 x 20 and 24 x 18 x 14 respectively with 0.375Å spacing, centred around the catalytic 
centre which was generated using AutoGrid in the AUTODOCK Tools interface. The number 
of runs for genetic algorithm was set to 10 and the rest of the docking parameters were set to 
default parameters. The dockings were performed by VINA, therefore the posed dockings 
were below 2Å rmsd.  The results generated by VINA were visualised in AUTODOCK Tools 
1.5.6 where the ligand conformations were assessed upon lowest VINA energy, but also the 
following criteria: The known mechanisms of short-chain ADHs [24] and experimentally-
determined enantioselectivity of both RasAH and SyADH for ketone 1 dictated that only 
poses in which the carbonyl of 1 was observed to make appropriate interactions with the 
phenolic hydroxyl of the catalytic tyrosine residue (Tyr150 or Tyr153 for RasADH or 
SyADH respectively); the conserved active site serine [22] (Ser137 or Ser140 for RasADH or 
SyADH respectively) and which presented the (re)-face of the carbonyl to the nicotinamide 
ring of NADPH (resulting in the (S)-alcohol product), were considered. 
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Table 1. Data Collection and Refinement Statistics for RasADH (apo- and in complex with 
NADPH) and SyADH in complex with NADPH.  Numbers in brackets refer to data for 
highest resolution shells. 
 RasADH (apo) RasADH (NADPH 
complex) 
SyADH (NADPH 
complex) 
Beamline Diamond I02 Diamond I04 Diamond I02 
Wavelength (Å) 0.97950 0.97950 0.97949 
Resolution (Å) 60.86-1.52 (1.57-
1.52) 
74.54-2.89 (2.93-
2.89) 
139.0 - 2.5 (2.56-
2.50) 
Space Group C21 C21 P21 
Unit cell (Å) a = 136.5; b = 52.5; c 
= 151.5;  =  = 90.0; 
 = 116.6 
a = 192.3; b = 135.6; 
c = 93.6;  =  = 
90.0;  = 100.1 
a = 144.9; b = 86.8; c 
= 155.6;  =  = 90.0; 
 = 106.4 
No. of molecules in 
the asymmetric unit 
4 6 10 
Unique reflections 149646 (45160) 52465 (3880) 133601 (10900) 
Completeness (%) 97.7 (96.8) 99.2 (98.8) 99.7 (99.8) 
Rmerge (%) 0.03 (0.25) 0.18 (0.73) 0.14 (0.54) 
Rp.i.m. 0.03 (0.23) 0.16 (0.64) 0.12 (0.46) 
Multiplicity 3.3 (3.5) 4.2 (4.2) 4.2 (4.3) 
<I/(I)> 15.6 (4.9) 7.4 (2.0) 8.2 (3.0) 
CC1/2 1.00 (0.95) 0.98 (0.74) 0.99 (0.82) 
Overall B factor 
from Wilson plot 
(Å
2
) 
24 41 43 
Rcryst/ Rfree (%) 15.8/18.8 26.8/29.3 23.4/25.1 
No. protein atoms 6942 11081 18948 
No. water molecules 846 37 290 
r.m.s.d 1-2 bonds 
(Å) 
0.02 0.01 0.01 
r.m.s.d 1-3 angles (
o
) 1.69 1.60 1.60 
Avge  main chain B 
(Å
2
) 
20 35 35 
Avge  side chain B 
(Å
2
) 
23 36 37 
Avge  water B (Å
2
) 33 14 20 
Avge  ligand B (Å
2
) - 32 30 
 
 
Figure Legends 
Figure 1. Representative asymmetric reductions of bulky-bulky ketones catalysed by alcohol 
dehydrogenases from Ralstonia sp. DSM 6428 (RasADH) and Sphingobium yanoikuyae 
DSM 6900  (SyADH). 
 
Figure 2.  Structure of RasADH.  a: The asymmetric unit of the apo-enzyme contained four 
monomers A-D that constituted one tetramer, which is shown in ribbon format and coloured 
by chain.  b: Monomer of RasADH apoenzyme (green ribbon) superimposed with monomer 
of RasADH holo-enzyme (coral ribbon) in complex with NADPH.  The r.m.s.d for the two 
structures over 201 C-alphas was 0.42 Å. The monomer(s) display the typical Rossman fold, 
with a central -sheet surrounded by six helices, four of which, 3, 4, 5 and 6.  Helix 6, 
which was absent in the apo-enzyme structure, appears to act as a lid to the active site, 
closing over the NADPH molecule when cofactor is bound.  The N and C termini of the apo- 
enzyme monomer are also indicated.  The cofactor NADPH is shown in cylinder format with 
carbon atoms shown in grey. 
 
Figure 3.  Structure of SyADH.  a: The asymmetric unit contains ten monomers that 
constitute five dimers shown in ribbon format and coloured by chain.  b: Each dimer consists 
of two monomers, coloured green and coral, each of which exhibits the Rossman ()8 fold, 
with eight helices (numbered 1-4 and 8 for the coral monomer; 5 is obscured)  
forming the central bundle and a ninth helix 9 that associates closely with the neighbouring 
monomer.  The N and C termini of the coral monomer are also indicated.  The cofactor 
NADPH is shown in cylinder format with carbon atoms shown in grey. 
Figure 4. Superimposition of active sites of RasADH and SyADH illustrating side-chain 
components of the hydrophobic tunnel in both active sites.  RasADH is shown in ribbon 
format in coral with side chains projecting from the backbone and the nicotinamide ring of 
NADPH (centre) shown (carbon atoms in coral).  SyADH is shown in light blue ribbons with 
NADPH and side chains (carbon atoms in light blue). 
 
Figure 5. Ketone 1 modelled into the active site of a) SyADH and b) RasADH using the 
programme AUTODOCK VINA [24].  In a), the carbon atoms of the side chains of SyADH 
are shown in light blue in cylinder format; 1 is shown in ball-and-stick format with the carbon 
atoms in black.  In b), the carbon atoms of the side chains of RasADH are shown in coral in 
cylinder format; 1 is again shown in ball-and-stick format with the carbon atoms in black.  
Distances are given in Ångstroms. 
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